Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-Toxoplasma gondii activities of 2,4-diaminotriazine-thiazole derivatives
Thiazole
Docking (animal)
IC50
DOI:
10.1007/s00044-018-2136-6
Publication Date:
2018-02-06T08:05:22Z
AUTHORS (10)
ABSTRACT
Synthesis, characterization, and investigation of antiproliferative activities against human cancer cell lines (MV4-11, MCF-7, A549) Toxoplasma gondii parasite twelve novel 2,4-diaminotriazine-thiazoles are presented. The toxicity the compounds was studied at three different types, normal mouse fibroblast (Balb/3T3), (L929), VERO cells. structures were determined using 1H 13C NMR, FAB(+)-MS, elemental analyses. Among derivatives, 4a-k showed very high activity MV4-11 line with IC50 values between 1.13 3.21 µg/ml. Additionally, cytotoxic Balb/3T3 cells is about 20-100 times lower than lines. According to our results, 4a, 4b, 4d, 4i have strong breast carcinoma from 3.18 4.28 Moreover, diaminotriazines 4a-l significant anti-Toxoplasma activity, 9-68 those observed for sulfadiazine. Molecular docking studies indicated DNA-binding site hTopoI hTopoII as possible anticancer targets purine nucleoside phosphorylase anti-toxoplasmosis target. Our UV-Vis spectroscopic results indicate also that diaminotriazine-thiazoles tends interact DNA by intercalation. structure interaction binding energies a model complex formed compound 4a two thymine molecules investigated quantum mechanical methods.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....